Definium Therapeutics, Inc.
DFTX
$42.63
-$1.27-2.89%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
5/23/2026
-
MarketBeat
8/14/2026
-
TipRanks
8/13/2026
-
The Cerbat Gem
8/13/2026
-
MarketBeat
8/13/2026
-
MarketBeat
8/13/2026
-
TipRanks
8/13/2026
-
Simply Wall St
8/13/2026
-
TipRanks
8/13/2026
-
TipRanks
8/13/2026
-
MarketBeat
8/13/2026
-
MarketBeat
8/13/2026
-
TipRanks
8/13/2026
-
MarketBeat
8/13/2026
-
Tickeron - Stocks
Definium Therapeutics (DFTX, $42.79) Stochastic Oscillator left the oversold zone on August 12, 2026
8/13/2026
-
Tickeron - Stocks
8/12/2026
-
Seeking Alpha: Transcripts
8/12/2026
-
SeekingAlpha
8/12/2026
-
Seeking Alpha - Healthcare
8/12/2026
-
Seeking Alpha - Long Ideas
8/12/2026
-
SeekingAlpha
8/12/2026
-
Nasdaq News: Markets
8/12/2026
-
MarketBeat
8/12/2026
-
MarketBeat
8/12/2026
-
TipRanks
8/12/2026
-
TipRanks
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
212 220 6633
Address
One World Trade Center
Suite 8500
New York, NY 10007
Suite 8500
New York, NY 10007
Country
Year Founded
--
Business Description
Sector
Definium Therapeutics, Inc., a clinical biopharmaceutical company, develops novel product candidates to treat brain health disorders. The company’s lead product candidates DT120, which is in...
more